Effects of Lipid Emulsion on the Pharmacokinetic and Pharmacodynamic Properties of Metoprolol.
Status:
Completed
Trial end date:
2017-03-10
Target enrollment:
Participant gender:
Summary
The aim of this study is to investigate whether intravenous lipid emulsion is effective in
attenuating the clinical effects of a cardioactive drug, exemplified by the beta-blocking
agent metoprolol. In addition, the investigators will clarify how intravenous lipid emulsion
affects the pharmacokinetic parameters of metoprolol.